Overview
Program
Asset
Registration
Community
87
IL22RA1high, mtKRAS_Colorectal cancer
Oxford University
Antibody
Oncology
Hit To Lead or Lead Optimization
Oxford researchers have indentified a proximal, IL22RA1high, KRAS mutant molecular CRC subtype.
PCT-GB2016-051466
Korea Drug Development Fund
6th KDDF Global C&D Tech Fair On-line Registration
6th KDDF Global C&D Tech Fair Partnering Meeting
TOP